SCHEMBL24372532

SCHEMBL24372532

c1ccc2cc(-c3nc(-c4ccc5c(ccc6ccccc65)c4)nc(-c4cccc5c4ccc4oc6ccccc6c45)n3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
ALDH1A1 P00352 5/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 4/20 0.38
TSHR P16473 3/20 0.38
CYP1A2 P05177 3/20 0.38
CASP1 P29466 2/20 0.38
MAPK1 P28482 2/20 0.38
FYN P06241 2/20 0.38
AHR P35869 2/20 0.38
ERBB2 P04626 1/20 0.38
MAOA P21397 1/20 0.38
ACHE P22303 1/20 0.38
HIF1A Q16665 1/20 0.38
CYP1A1 P04798 2/20 0.38
CYP1B1 Q16678 1/20 0.38
MAPT P10636 5/20 0.37
KDM4E B2RXH2 3/20 0.37
KMT2A Q03164 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22879791 0.96 L3MBTL1 (0.39) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL22879790 0.95 TDP1 (0.43) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL25505078 0.95 L3MBTL1 (0.40) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL25505224 0.94 HCRTR1 (0.37) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL25660704 0.94 ALDH1A1 (0.41) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL25505076 0.94 TDP1 (0.38) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL22880407 0.93 ALDH1A1 (0.42) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL24306986 0.92 L3MBTL1 (0.41) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL23822640 0.91 L3MBTL1 (0.39) L3MBTL1TDP1ALDH1A1HPGDHSD17B10
SCHEMBL25660660 0.91 ALDH1A1 (0.38) L3MBTL1TDP1ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230371374-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-11-16 US disclosed
US-20230371374-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-11-16 US disclosed
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2023-05-18 US disclosed
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2023-05-18 US disclosed
US-20220131083-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230371374-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SOD1, TELO2, LIMS1 L3MBTL1 84/4885TDP1 363/4885ALDH1A1 530/4885
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, VDAC2, ICOSLG L3MBTL1 1328/4885TDP1 643/4885ALDH1A1 604/4885
US-20220131083-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME TELO2, TERT, LIMS1 L3MBTL1 33/4885TDP1 319/4885ALDH1A1 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.